Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade C 6.47 -4.15% -0.28
AUPH closed down 4.15 percent on Friday, March 22, 2019, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical AUPH trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Fell Below 50 DMA Bearish 0.00%
Mar 22 Earnings Movers Other 0.00%
Mar 21 Bearish Engulfing Bearish -4.15%
Mar 21 20 DMA Support Bullish -4.15%
Mar 21 50 DMA Support Bullish -4.15%
Mar 21 Calm After Storm Range Contraction -4.15%
Mar 21 Earnings Movers Other -4.15%
Mar 20 Crossed Above 20 DMA Bullish -5.27%
Mar 20 Crossed Above 50 DMA Bullish -5.27%

Older signals for AUPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Medicine Biopharmaceutical Life Sciences Drugs Autoimmune Diseases Immunosuppressants Peptides Lupus Lupus Nephritis Treatment Of Lupus
Is AUPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.85
52 Week Low 5.01
Average Volume 1,016,681
200-Day Moving Average 5.9564
50-Day Moving Average 6.6206
20-Day Moving Average 6.565
10-Day Moving Average 6.414
Average True Range 0.3012
ADX 14.89
+DI 27.2014
-DI 15.629
Chandelier Exit (Long, 3 ATRs ) 6.4764
Chandelier Exit (Short, 3 ATRs ) 6.9036
Upper Bollinger Band 7.1435
Lower Bollinger Band 5.9865
Percent B (%b) 0.42
BandWidth 17.623762
MACD Line -0.0075
MACD Signal Line -0.0327
MACD Histogram 0.0252
Fundamentals Value
Market Cap 540.15 Million
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -4.98
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.03
Resistance 3 (R3) 7.09 6.96 6.93
Resistance 2 (R2) 6.96 6.82 6.93 6.90
Resistance 1 (R1) 6.72 6.73 6.66 6.66 6.87
Pivot Point 6.59 6.59 6.56 6.56 6.59
Support 1 (S1) 6.35 6.45 6.29 6.29 6.07
Support 2 (S2) 6.22 6.36 6.19 6.04
Support 3 (S3) 5.98 6.22 6.01
Support 4 (S4) 5.92